Your browser doesn't support javascript.
loading
Potent Antibody Response Elicited by a Third Booster Dose of Inactivated COVID-19 Vaccine in Healthy Subjects.
Ji, Ruili; Zhang, Jiaqi; Liang, Dan; Quan, Hongbing; Wu, Yue; Peng, Aiping; Li, Weili; Lu, Shaofang; Zhang, Xuedong; Ke, Changwen; Wang, Dawei; Xu, Jianhua.
Afiliación
  • Ji R; Department of Laboratory Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China.
  • Zhang J; The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Liang D; Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
  • Quan H; Guangdong Provincial Center for Disease Control and Prevention, Guangdong Workstation for Emerging Infectious Disease Control and Prevention, Guangzhou, China.
  • Wu Y; Department of Laboratory Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China.
  • Peng A; Department of Laboratory Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China.
  • Li W; Emergency Department, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China.
  • Lu S; Research and Development Centers, and Autobio Diagnostics Co. Ltd., Zhengzhou, China.
  • Zhang X; Department of Laboratory Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China.
  • Ke C; Department of Medical Affairs, Autobio Diagnostics Co. Ltd., Zhengzhou, China.
  • Wang D; Guangdong Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou, China.
  • Xu J; Department of Pulmonary and Critical Care Medicine, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China.
Viral Immunol ; 36(9): 593-599, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37782911
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Aged / Female / Humans / Male Idioma: En Revista: Viral Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / VIROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Aged / Female / Humans / Male Idioma: En Revista: Viral Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / VIROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos